Education
About Us
Working with TipRanks
Follow Us
Solara Active Pharma Sciences Ltd. (IN:SOLARA)
:SOLARA
Total Valuation
Solara Active Pharma Sciences Ltd. has a market cap or net worth of ₹32.58B. The enterprise value is ₹41.26B.
Market Cap₹32.58B
Enterprise Value₹41.26B
Share Statistics
Solara Active Pharma Sciences Ltd. has 48,153,023 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding48,153,023
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Solara Active Pharma Sciences Ltd.’s return on equity (ROE) is <0.01 and return on invested capital (ROIC) is 22.83%.
Return on Equity (ROE)<0.01
Return on Assets (ROA)<0.01
Return on Invested Capital (ROIC)22.83%
Return on Capital Employed (ROCE)0.35
Revenue Per Employee5.95M
Profits Per Employee2.50K
Employee Count2,156
Asset Turnover0.58
Inventory Turnover1.97
Valuation Ratios
The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio―
PS Ratio0.00
PB Ratio1.43
Price to Fair Value1.81
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio29.28
Income Statement
In the last 12 months, Solara Active Pharma Sciences Ltd. had revenue of 12.84B and earned 5.40M in profits. Earnings per share was 0.14.
Revenue12.84B
Gross Profit6.57B
Operating Income4.46B
Pretax Income5.40M
Net Income5.40M
EBITDA2.06B
Earnings Per Share (EPS)0.14
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Solara Active Pharma Sciences Ltd. pays an annual dividend of ₹3, resulting in a dividend yield of ―
Dividend Per Share₹3
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.17
52-Week Price Change7.22%
50-Day Moving Average558.82
200-Day Moving Average614.58
Relative Strength Index (RSI)68.61
Average Volume (3m)26.59K
Important Dates
Solara Active Pharma Sciences Ltd. upcoming earnings date is Nov 6, 2025, TBA (Confirmed).
Last Earnings DateJul 25, 2025
Next Earnings DateNov 6, 2025
Ex-Dividend DateAug 18, 2021
Financial Position
Solara Active Pharma Sciences Ltd. as a current ratio of 0.77, with Debt / Equity ratio of 72.75%
Current Ratio0.77
Quick Ratio0.44
Debt to Market Cap0.39
Net Debt to EBITDA3.84
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Solara Active Pharma Sciences Ltd. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Solara Active Pharma Sciences Ltd. EV to EBITDA ratio is 13.42, with an EV/FCF ratio of 16.01.
EV to Sales2.16
EV to EBITDA13.42
EV to Free Cash Flow16.01
EV to Operating Cash Flow13.01
Balance Sheet
Solara Active Pharma Sciences Ltd. has ₹41.10M in cash and marketable securities with ₹7.96B in debt, giving a net cash position of ₹7.92B billion.
Cash & Marketable Securities₹41.10M
Total Debt₹7.96B
Net Cash₹7.92B
Net Cash Per Share₹164.47
Tangible Book Value Per Share₹182.06
Margins
Gross margin is 38.89%, with operating margin of 34.72%, and net profit margin of 0.04%.
Gross Margin38.89%
Operating Margin34.72%
Pretax Margin0.04%
Net Profit Margin0.04%
EBITDA Margin16.07%
EBIT Margin8.34%
Analyst Forecast
The average price target for Solara Active Pharma Sciences Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-3.16%
EPS Growth Forecast99.26%